Giuseppe Tarantini
Overview
Explore the profile of Giuseppe Tarantini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
669
Citations
5721
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Aarts H, van Nieuwkerk A, Hemelrijk K, Salgado Fernandez J, Tchetche D, de Brito Jr F, et al.
JACC Cardiovasc Interv
. 2025 Jan;
18(1):89-99.
PMID: 39814498
Background: Transcatheter aortic valve replacement (TAVR) harbors the risk of periprocedural complications that require emergent cardiac surgery, or "surgical bailout." Surgical bailout intends to be lifesaving but is associated with...
12.
Tarantini G, Tang G, Pilgrim T, Kim W, Greenbaum A, Castriota F, et al.
JACC Cardiovasc Interv
. 2025 Jan;
18(1):103-115.
PMID: 39814484
Background: Lifetime treatment of aortic valve disease is a matter of increasing debate. Although the risks of a second aortic valve intervention are recognized, little attention has been given to...
13.
Haberman D, Estevez-Loureiro R, Czarnecki A, Melillo F, Adamo M, Villablanca P, et al.
Eur J Heart Fail
. 2025 Jan;
PMID: 39809715
Aims: To evaluate the association between transcatheter edge-to-edge repair (TEER) and outcomes in patients with significant mitral regurgitation (MR) following acute myocardial infarction (MI), focusing on the aetiology of acute...
14.
Schafer A, Alasnag M, Giacoppo D, Collet C, Rudolph T, Roguin A, et al.
EuroIntervention
. 2025 Jan;
21(1):22-34.
PMID: 39773827
This clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions was developed in association with the European Society of Cardiology Working Group on Cardiovascular Surgery. It aims to...
15.
Piccolo R, Calabro P, Carrara G, Varricchio A, Baldi C, Napolitano G, et al.
EuroIntervention
. 2025 Jan;
21(1):58-72.
PMID: 39773824
Background: Few data are available on polymer-free drug-eluting stents in patients undergoing percutaneous coronary intervention (PCI). Aims: We aimed to determine the efficacy and safety of a polymer-free amphilimus-eluting stent...
16.
Castaldi B, Ciarmoli E, Di Candia A, Sirico D, Tarantini G, Scattolin F, et al.
Int J Cardiol Congenit Heart Dis
. 2024 Dec;
8:100389.
PMID: 39712041
Percutaneous aortic coarctation treatment with primary stent implantation is the first choice in adult patients. However, current guidelines do not suggest a lower weight limit to perform this procedure safely....
17.
Tarantini G, Fovino L
Circ Cardiovasc Interv
. 2024 Dec;
17(12):e014891.
PMID: 39689191
No abstract available.
18.
Stolz L, Kresoja K, von Stein J, Fortmeier V, Koell B, Rottbauer W, et al.
JACC Cardiovasc Interv
. 2024 Dec;
17(23):2781-2791.
PMID: 39663058
Background: Atrial secondary tricuspid regurgitation (A-STR) has been proposed as an important etiologic subentity of secondary tricuspid regurgitation (STR). Patients with A-STR are frequently treated using transcatheter tricuspid valve edge-to-edge...
19.
Corcione N, Ferraro P, Finizio F, Cimmino M, Albanese M, Morello A, et al.
Int J Cardiol
. 2024 Dec;
421():132874.
PMID: 39662752
Background: Tethering is a common condition of the mitral valve apparatus in the presence of significant regurgitation. Its impact on outcomes of transcatheter edge-to-edge repair (TEER) remains poorly characterized. Methods:...
20.
Tarantini G, Cardaioli F
Lancet
. 2024 Dec;
404(10471):2492-2493.
PMID: 39644912
No abstract available.